Germina Agribusiness S.A. (BVB:SEOM)
1.660
0.00 (0.00%)
At close: Aug 1, 2025
Verve Therapeutics Balance Sheet
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Jan '21 Jan 1, 2021 | 2015 - 2019 |
Cash & Equivalents | 2 | 7.72 | 8.22 | 44.58 | 7.96 | Upgrade |
Short-Term Investments | 5.78 | 0.24 | 0.18 | 0.23 | 0.25 | Upgrade |
Cash & Short-Term Investments | 7.78 | 7.96 | 8.4 | 44.81 | 8.2 | Upgrade |
Cash Growth | -2.30% | -5.21% | -81.26% | 446.19% | 1044.39% | Upgrade |
Accounts Receivable | 0.11 | 0.12 | 0.02 | 15.43 | 26.99 | Upgrade |
Other Receivables | 0.27 | 0.54 | 1.76 | 2.6 | 3.01 | Upgrade |
Receivables | 0.38 | 0.67 | 1.78 | 18.03 | 30 | Upgrade |
Inventory | - | 0 | 0 | 0.19 | 6.06 | Upgrade |
Prepaid Expenses | 0.01 | 0 | - | 0.03 | 0.08 | Upgrade |
Total Current Assets | 8.16 | 8.63 | 10.18 | 63.07 | 44.35 | Upgrade |
Property, Plant & Equipment | 3.6 | 9.11 | 15.11 | 17.27 | 37.5 | Upgrade |
Long-Term Investments | - | - | - | - | 0.14 | Upgrade |
Other Intangible Assets | 0 | 0 | 0.03 | 0.08 | 0.19 | Upgrade |
Other Long-Term Assets | - | - | 0.02 | 0.08 | 0.03 | Upgrade |
Total Assets | 11.77 | 17.74 | 25.34 | 80.5 | 82.21 | Upgrade |
Accounts Payable | 0.03 | 0.01 | 0.06 | 3.54 | 7.3 | Upgrade |
Accrued Expenses | 0.07 | 0.04 | 0.04 | 1.92 | 0.31 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | - | 6.87 | Upgrade |
Current Portion of Leases | - | - | - | - | 1.74 | Upgrade |
Current Unearned Revenue | - | - | - | 4.02 | 4.04 | Upgrade |
Other Current Liabilities | 2.53 | 2.32 | 2.01 | 0.89 | 5.44 | Upgrade |
Total Current Liabilities | 2.64 | 2.38 | 2.11 | 10.37 | 25.7 | Upgrade |
Long-Term Debt | - | - | - | - | 1.57 | Upgrade |
Long-Term Leases | - | - | - | - | 0.52 | Upgrade |
Long-Term Unearned Revenue | - | - | 0.01 | 0.04 | - | Upgrade |
Other Long-Term Liabilities | 0.86 | 0.92 | 0.27 | 0.95 | 0.44 | Upgrade |
Total Liabilities | 3.49 | 3.3 | 2.39 | 11.36 | 28.23 | Upgrade |
Common Stock | 1.35 | 1.35 | 1.35 | 33.77 | 33.77 | Upgrade |
Retained Earnings | 5.91 | 10.1 | 16.69 | 29.34 | 9.62 | Upgrade |
Comprehensive Income & Other | 1.01 | 3 | 4.9 | 6.03 | 10.59 | Upgrade |
Shareholders' Equity | 8.27 | 14.45 | 22.94 | 69.14 | 53.98 | Upgrade |
Total Liabilities & Equity | 11.77 | 17.74 | 25.34 | 80.5 | 82.21 | Upgrade |
Total Debt | - | - | - | - | 10.7 | Upgrade |
Net Cash (Debt) | 7.78 | 7.96 | 8.4 | 44.81 | -2.49 | Upgrade |
Net Cash Growth | -2.30% | -5.21% | -81.26% | - | - | Upgrade |
Net Cash Per Share | 0.58 | 0.59 | 0.62 | 3.32 | -0.18 | Upgrade |
Filing Date Shares Outstanding | 13.51 | 13.51 | 13.51 | 13.51 | 13.51 | Upgrade |
Total Common Shares Outstanding | 13.51 | 13.51 | 13.51 | 13.51 | 13.51 | Upgrade |
Working Capital | 5.53 | 6.25 | 8.07 | 52.7 | 18.65 | Upgrade |
Book Value Per Share | 0.61 | 1.07 | 1.70 | 5.12 | 4.00 | Upgrade |
Tangible Book Value | 8.27 | 14.44 | 22.91 | 69.07 | 53.79 | Upgrade |
Tangible Book Value Per Share | 0.61 | 1.07 | 1.70 | 5.11 | 3.98 | Upgrade |
Land | - | - | 5.12 | 5.49 | 11.77 | Upgrade |
Buildings | - | - | 9.58 | 12.41 | 19.2 | Upgrade |
Machinery | 2.48 | 3.09 | 4.43 | 8.59 | 26.8 | Upgrade |
Construction In Progress | - | - | - | - | 0.05 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.